GDF1 and hepatocellular carcinoma: To test the effect of GDF1 in the HCC immune response, HCC patients from the TCGA–LIHC project were divided into three subgroups (the activated immune group, exhausted immune group, and remaining group) according to the specified classifiers (Supplementary Fig. 6).